Our tired reporter flight-tests a product to combat jet lag

Article Abstract:

Menuco Corp.conducts an experiment to test its anti jet lag drug nicotinamide adenine dinucleotide hydrogen, sold as ENADAlert. The experiment was conucted on several volunteers on a cross country flight with mild results.

Pharmaceutical Preparations, Care and treatment, Drugs, Testing, Jet lag, Menuco Corp., ENADAlert (Medication)

---

How drug giant keeps a monopoly on 60-Year-Old pill: Barr strikes out in bid to sell copy of Wyeth's Premarin; lessons for biotech world: the secrets of horses' urine

Article Abstract:

Generic drug manufacturer Barr Laboratories has been trying to replicate Premarin for over 15 years. The estrogen replacement drug is owned and manufactured by Wyeth, whose patent expired decades ago.

Generic Drugs, Composition, BRL, Premarin (Medication), Barr Laboratories Inc.

---

Rhone-Poulenc antibiotic wins approval in the U.S

Article Abstract:

Rhone-Poulenc SA's Synercid antibiotic drug has been given approval for sale in the US by the Food and Drug Administration (FDA). The drug treats some infections that are immune to all other types of drugs. Synercid is designed to also treat infections that have been acquired during a hospital stay. The FDA mentioned that the Vancomycin drug was seeing stronger resistance from infections.

Comment:

Synercid antibiotic drug given approval for sale in the US by FDA

Product information, Systemic Antibiotic Preparations, Antibiotics, Abstract, Rhone-Poulenc S.A.

Similar abstracts:

• Abstracts: Russia's oil output begins to taper off: rate of growth is slowing; industry probe and threat of higher taxes also loom
• Abstracts: Cortefiel launches 78 million euros bid for beleaguered Adolfo Dominguez. Azucarera agrees to acquire Puleva in 590 million euros deal
• Abstracts: Some Asian airlines appear ready for Y2K: analysts are most confident about the preparedness of major carriers
• Abstracts: Accent on chocolate: eager to boost M&M sales in La Belle Province, Mars launches its first Quebec-Specific campaign in over a decade
• Abstracts: Bioengineered food fight in EU is coming soon: consumers have a choice with global consequences: Monsanto vs. Greenpeace

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.